MoneyWorks4Me

Medicamen Biotech’s Bhiwadi Formulation facility gets final EU GMP Certification

11 Sep 2024 Evaluate

Medicamen Biotech’s General Tablets and Liquid Orals Formulation facility located at Phase IV, Industrial Area, Bhiwadi has received the final approval (EU GMP Certification) on September 11, 2024 from the Inspection Department, Division of Production & Distribution Control, National Organisation for Medicines, GREECE.

Medicamen Biotech is engaged in manufacturing and marketing of pharmaceutical formulations in overseas and domestic markets.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..